GPR80 antagonists (Omeros)

N/A

Report date: 2025/03/20 14:53:30
NME

Base Information

Drug NameGPR80 antagonists (Omeros)
Drug Alias Name2 oxoglutarate receptor 1 antagonists (Omeros)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action2-oxoglutarate receptor 1 antagonists
Targets2-oxoglutarate receptor 1
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmeros Corp
China Registration ClassN/A

Develop Information

Active CompaniesOmeros Corp
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A